A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver

NCT00191412 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: Pemetrexed

Sponsor

Eli Lilly and Company